Corcept Therapeutics
CORT
#2296
Rank
$8.21 B
Marketcap
$75.02
Share price
3.10%
Change (1 day)
-0.62%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2023 (TTM): $0.88

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is $0.52. In 2022 the company made an earnings per share (EPS) of $0.95 a decrease over its 2021 EPS that were of $0.97.

EPS history for Corcept Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.88-7.37%
2022$0.95-2.06%
2021$0.975.43%
2020$0.9210.84%
2019$0.8327.69%
2018$0.65-42.48%
2017$1.131518.29%
2016$0.06983-199.75%
2015-$0.07000-77.42%
2014-$0.31-32.61%
2013-$0.4612.2%
2012-$0.412.5%
2011-$0.402.56%
2010-$0.392.63%
2009-$0.38-11.63%
2008-$0.4326.47%
2007-$0.34-68.81%
2006-$1.0923.86%
2005-$0.88-1.12%
2004-$0.89-27.05%
2003-$1.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68 1,185.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$5.25 909.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$0.76 46.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$30.87 5,835.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$0.99 90.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$4.52 769.23%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-$0.13-125.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-$0.02000-103.85%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.38-26.92%๐Ÿ‡บ๐Ÿ‡ธ USA